Axsome Therapeutics announced it is joining advocacy organizations around the world to help raise awareness of Alzheimer’s disease and to stand in solidarity with all those affected by this condition and their families during Alzheimer’s Disease Awareness Month. November marks Alzheimer’s Disease Awareness Month, an important time to know the facts about this illness that affects millions.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on AXSM:
- Axsome Therapeutics to Present at Upcoming Investor Conferences
- Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
- Axsome Therapeutics presents results of the ACCORD trial of AXS-05
- Axsome Therapeutics Presents Results of the ACCORD trial of AXS-05 in Alzheimer’s Disease Agitation at the Clinical Trials on Alzheimer’s Disease (CTAD) 2023 Conference
- Axsome Therapeutics appoints Mahony to board of directors
Questions or Comments about the article? Write to editor@tipranks.com